Chinese conglomerate Dalian Wanda Group Co, one of the biggest theatre operators in the United States, is in talks to buy a stake in U.S. film studio Lions Gate Entertainment Corp, Bloomberg News said on Monday.

Discussions between Lions Gate and Wanda are "at an early stage and may not lead to a deal," Bloomberg reported, citing an interview with Wanda's Chairman Wang Jianlin.

Wang's comments are the latest sign of the company's interest in making further inroads into the U.S. film industry. It comes three days after Wanda Cinema Line Co Ltd, a movie theatre company controlled by Wang, received approval for a share-offering in China in which it hopes to raise up to 2 billion yuan.

A spokesman for Wanda could not be reached for comment. A Lions Gate spokesman declined comment.

Wang, who Forbes magazine says is China's fourth-richest man, said the owners of Lion Gate "have only been willing to sell a minority stake," according to Bloomberg. He said he was also in talks about investing in Metro-Goldwyn-Mayer Inc.

In 2012, Wanda bought U.S. cinema chain AMC Entertainment Holdings Inc for $2.6 billion, including about $2 billion in assumed debt. The deal was the largest overseas acquisition by a privately held Chinese firm and Wanda's first investment outside China.

In August, Wanda announced it had won the bid for a plot of land in Beverly Hills and would spend $1.2 billion for a development there as its "first important step into Hollywood."

Wang said his company was shifting its focus toward culture, entertainment and e-commerce, according to the Bloomberg report.

Chinese real estate developer Dalian Wanda Commercial Properties, a unit of the Dalian Wanda Group, has won approval from Hong Kong's stock exchange for an initial public offering, which could be worth up to $6 billion, according to a source with direct knowledge of the matter.

In July, Chinese e-commerce giant Alibaba Group signed a deal with Lions Gate, the studio behind the "Hunger Games" films, to launch a subscription streaming service in China.


 

Related Articles

海问、凯易助力港交所18A企业第一宗反向收购案例(ZH/EN)

近日,港交所18A上市企业嘉和生物宣布与亿腾医药达成合并协议,合并后企业将更名为亿腾嘉和医药集团有限公司。海问律师事务所担任嘉和生物的法律顾问,凯易国际律师事务所则代表亿腾医药参与交易。

贝克·麦坚时、高伟绅、金杜助力海尔智家7.75亿美元收购美国开利商用业务(ZH/EN)

海尔集团旗下公司海尔智家于近期完成了对开利全球公司旗下的开利商用制冷业务的收购,交易对价约为7.75亿美元,这是中国投资者实施“走出去”战略的又一重大交易。

2024 ALB China 并购排名 (ZH/EN)

过去一年,受到宏观经济趋势、国际政治局势、资本市场监管趋严等因素影响,中国的并购市场经受极大挑战,也面临着多重变化。在这一背景下,今年上榜ALB并购业务排名的律师事务所展现出强大的业务韧性,以及跟随市场需求而变的灵活性。